Last Price$15.13.3%
Market Cap$3,703.3M
LTM Pre-tax Income
$33.4M
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
6/10
57.0% undervalued
Oscar Health, Inc. Pre-tax Income
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
| Pre-tax Income | ($259.4M) | ($405.8M) | ($570.6M) | ($610.1M) | ($267.3M) | $33.4M |
Overvalued or undervalued?
Check the intrinsic value for OSCR
and see if it's the right time to invest.
Oscar Health, Inc. (OSCR) Pre-tax Income comparison analysis
General
LTM Pre-tax Income
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Oscar Health, Inc.OSCR
$33.4M
N/A
N/A
N/A
Median Peer Set
$2,989.0M
(18.5%)
(5.8%)
0.0%
UnitedHealth Group IncorporatedUNH
$20.1B
(31.1%)
(3.5%)
2.2%
Elevance Health Inc.ELV
$7,904.0M
2.4%
(0.1%)
5.7%
CVS Health CorporationCVS
$6,148.0M
(45.0%)
(16.1%)
(7.3%)
Cigna CorporationCI
$5,269.0M
(4.4%)
(8.1%)
(4.3%)
Centene CorporationCNC
$4,257.0M
18.3%
32.9%
19.0%
Humana Inc.HUM
$1,721.0M
(49.1%)
(19.9%)
(13.0%)
Molina Healthcare, Inc.MOH
$1,589.0M
8.5%
22.0%
10.3%
Clover Health Investments, Corp.CLOV
($47.2M)
(77.9%)
(56.8%)
(30.2%)
Alignment Healthcare, Inc.ALHC
($128.1M)
(13.6%)
(13.1%)
N/A
Bright Health Group, Inc.BHG
($670.0M)
(23.5%)
37.5%
N/A
OSCR key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
% growth | 553.8 0.0% | 589.6 6.5% | 1,921.0 225.8% | 4,125.6 114.8% | 5,862.9 42.1% | 9,177.6 56.5% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
% margin | 553.8 100.0% | 589.6 100.0% | 1,921.0 100.0% | 4,125.6 100.0% | 5,862.9 100.0% | 9,177.6 100.0% |
| Operating Expenses | (814.2) | (996.5) | (2,498.0) | 4,553.5 | 6,098.5 | 9,120.3 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 110.7 | 166.7 | 265.1 | 309.8 | 339.7 | 1,755.9 |
% margin | (260.5) (47.0%) | (406.9) (69.0%) | (577.1) (30.0%) | (584.2) (14.2%) | (235.6) (4.0%) | 57.3 0.6% |
| Interest Income | 11.1 | 8.0 | 10.3 | 31.3 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 3.5 | 4.7 | 22.6 | 24.6 | 23.7 |
| Pre-tax Income | (259.4) | (405.8) | (570.6) | (610.1) | (267.3) | 33.4 |
% effective tax rate | 1.8 (0.7%) | 1.0 (0.3%) | 0.8 (0.1%) | (0.5) 0.1% | 3.3 (1.2%) | 7.3 21.9% |
% margin | (261.2) (47.2%) | (406.8) (69.0%) | (571.4) (29.7%) | (609.6) (14.8%) | (270.7) (4.6%) | 25.4 0.3% |
| EPS | (1.09) | (1.70) | (3.19) | (2.87) | (1.22) | 0.11 |
| Diluted EPS | (1.09) | (1.70) | (3.19) | (2.87) | (1.22) | 0.10 |
% margin | (252.5) (45.6%) | (391.0) (66.3%) | (551.3) (28.7%) | (572.2) (13.9%) | (212.0) (3.6%) | 88.6 1.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Oscar Health, Inc.'s Pre-tax Income?
As of today, Oscar Health, Inc.'s last 12-month Pre-tax Income is $33.4M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Oscar Health, Inc.'s Pre-tax Income growth rate?
Over the last year, Oscar Health, Inc.'s Pre-tax Income growth was N/A. The average annual Pre-tax Income growth rates for Oscar Health, Inc. have been N/A over the past three years, N/A over the past five years.